Health Care & Life Sciences » Pharmaceuticals | Shandong Xinhua Pharmaceutical Co. Ltd.

Shandong Xinhua Pharmaceutical Co. Ltd. | Income Statement

Fiscal year is January-December. All values HKD Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
3,998
4,517
4,436
4,632
5,137
6,095
Cost of Goods Sold (COGS) incl. D&A
3,387
3,628
3,441
3,550
3,784
4,362
Gross Income
612
889
996
1,082
1,353
1,733
SG&A Expense
511
677
722
814
986
1,266
EBIT
45
155
191
242
346
420
Unusual Expense
-
6
14
3
6
31
Non Operating Income/Expense
27
83
44
27
27
53
Interest Expense
87
99
112
88
73
70
Pretax Income
60
115
145
187
309
385
Income Tax
15
29
29
31
54
60
Equity in Affiliates
3
-
-
-
-
-
Consolidated Net Income
48
86
116
155
255
325
Net Income
46
64
102
143
242
297
Net Income After Extraordinaries
46
64
102
143
242
297
Net Income Available to Common
46
64
102
143
242
297
EPS (Basic)
0.08
0.11
0.17
0.24
0.40
0.48
Basic Shares Outstanding
595
595
595
595
605
622
EPS (Diluted)
0.08
0.11
0.17
0.24
0.40
0.48
Diluted Shares Outstanding
595
595
595
595
605
622
EBITDA
280
408
472
527
667
772
Other Operating Expense
55
58
83
26
21
47
Non-Operating Interest Income
4
6
6
6
3
5
Minority Interest Expense
2
22
14
13
13
28

About Shandong Xinhua Pharmaceutical Co.

View Profile
Address
No. 1 Lutai Avenue
Zibo Shandong 255086
China
Employees -
Website http://www.xhzy.com
Updated 07/08/2019
Shandong Xinhua Pharmaceutical Co., Ltd. engages in the development, production and sales of pharmaceutical and synthetic chemical products. It operates the business through the following segments: Bulk Pharmaceuticals, Preparations, Chemical and Other Products. The firm's products include analgin, caffeine, amidopyrine, ibuprofen, theophylline, aspirin, hydrocortisone and pipemidic acid.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.